The device intended for the quantitative in vitro determination of Creatinine in serum, plasma or urine

The is intended for the quantitative in vitro diagnostic determination of Creatinine in serum, plasma or urine

Randox Cytokine high sensitivity controls are intended for use as an assayed quality control in the routine monitoring of accuracy and precision for the analytes listed in this insert. The Randox Cytokine high sensitivity controls are multi-analyte. Each control contains all of the analytes listed overleaf. There are 3 levels of control: low, medium and high; Level 1, 2 and 3 respectively.

Randox Cytokine controls are intended for use as an assayed quality control in the routine monitoring of accuracy and precision for the analytes listed in this insert.The Randox Cytokine Controls are multi-analyte. Each control contains all of the analytes listed overleaf. There are 3 levels of control: low, medium and high; Level 1, 2 and 3 respectively.

The Randox Ammonia Ethanol Control Level 1 is intended for in vitro diagnostic use, in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems.

The Randox Ammonia Ethanol Control - Level 2 is intended for in vitro diagnostic use, in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems.

The Randox Ammonia Ethanol Control - Level 3 is intended for in vitro diagnostic use, in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems.

The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.

Chemiluminescent substrate comprised of 1 bottle of Luminol Reagent - EV805 and 1 bottle of Peroxide Reagent. The analyser uses a 1:1 mixture of the two solutions as a working signal reagent to generate a chemiluminescent signal which can be detected by the imaging module of the Evidence™ analyser.

The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.

Evidence® Drugs of Abuse Calibrators are intended for in vitro diagnostic use in the calibration of the Randox Drugs of Abuse Panel on the Evidence® analyser.

Diluted displacement fluid is used to wash the Evidence™ reagent tubing between dispenses.

Diluted wash buffer is used for washing the biochips between assay steps to remove all unbound materials.

Chemiluminescent substrate comprised of 1 bottle of Luminol Reagent - EV701 and 1 bottle of Peroxide Reagent. The analyser uses a 1:1 mixture of the two solutions as a working signal reagent - EV701 to generate a chemiluminescent signal which can be detected by the imaging module of the Evidence™ analyser.

This product is intended for the quantitative in vitro determination of Ferritin in serum or plasma.

This product is intended for the quantitative in vitro determination of Ferritin in serum or plasma.

This product is intended for the quantitative in vitro determination of Ferritin in serum or plasma.

This product is intended for in vitro diagnostic use in the calibration of the Randox Liquid Fructosamine assay on clinical chemistry systems.

This product is intended for in vitro diagnostic use in the quality control of the Randox Liquid Fructosamine assay on clinical chemistry systems.

This product is intended for in vitro diagnostic use in the quality control of the Randox Liquid Fructosamine assay on clinical chemistry systems.

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A Glucose test system is a device intended for the quantitative in vitro determination of glucose concentration in serum, plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A Glucose test system is a device intended for the quantitative in vitro determination of glucose concentration in serum, plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

A Glucose test system is a device intended for the quantitative in vitro determination of glucose concentration in serum, lithium plasma and urine

A Glucose test system is a device intended for the quantitative in vitro determination of glucose concentration in serum, lithium plasma and urine

A glucose test system is a device intended for the quantitative in vitro determination of Glucose concentration in serum, plasma and urine

The product is intended for the quantitative in vitro determination of Glucose in serum, plasma or urine.

The product is intended for the quantitative in vitro determination of Glucose in serum, plasma or urine.

A GGT test system is a device intended for the quantitative in vitro determination of L Gamma Glutamyltransferase (GGT) activity in serum and plasma. This product is suitable for use on RX series instruments which includes the RX daytona and the RX imola.

A Gamma GT test system is a device intended for the quantitative in vitro determination of L Gamma Glutamyltransferase (GGT) activity in serum and plasma.

This product is intended for in vitro diagnostic use in the calibration of HbA1c on clinical chemistry systems.

A Haemoglobin A1c test system is a device intended for the quantitative in vitro determination of Haemoglobin A1c concentration in whole blood

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. TheDrug Controls are for the control of accuracy and precision.

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. The Drug Controls are for the control of accuracy and precision.

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. The Drug Controls are for the control of accuracy and precision.

The Human Assayed Multi-sera is supplied at 2 levels, level 2 and 3. Target values and ranges are supplied for the analytes listed in the values section at both levels.